ATP6AP2 and immune system disorder: Genetic reduction of ATP6AP2 for example by hemizygous missense mutations in the extracellular domain of the accessory V-ATPase subunit of ATP6AP2 has been described to lead to a glycosylation disorder with liver disease, immunodeficiency, cutis laxa, and psychomotor impairment [57].